Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.19 USD | -1.65% | -0.83% | -12.50% |
03-21 | North American Morning Briefing : Investors -2- | DJ |
03-14 | AVROBIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.50% | 53.38M | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+1.75% | 22.18B | |
-16.67% | 21.2B | |
-8.77% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- AVRO Stock
- News AVROBIO, Inc.
- Avrobio : Says FDA Approval of Sanofi's Fabrazyme Leaves Head-to-Head Trial as Best Path for Its Fabry Disease Treatment; Stock Sinks